Video & Transcript : 'FDA user fees' :

Page 54 of 500
NH

New Hampshire 2026 Regular Session

House Health, Human Services and Elderly Affairs (02/25/2026)

Health, Human Services and Elderly Affairs

Transcript Highlights:
  • And it's not FDA approved for pain, but people are still using it.
  • And it's not FDA<01:20:25.280><c> approved</c><01:20:25.600><c> for</c><01:20:25.760><c> pain,</c><01
  • I would look at the FDA language and match that.
  • is already regulated and how the FDA is already regulated and how their<01:25:09.920><c> language.
  • I would look at the FDA their language.
CA

California 2025-2026 Regular Session

Senate Business, Professions and Economic Development Committee Apr 6th, 2026

Business, Professions and Economic Development

Transcript Highlights:
  • We, because of state law, cannot have our members receive lower-cost, equally effective, FDA-approved
  • Even when the biosimilar is FDA-approved and clinically equivalent for that patient, this means that
  • This is what the FDA is finding out and they’re changing their policies.
  • But first of all, there’s the drug itself, which has gone through the FDA for initial approval.
  • So FDA doesn’t recognize the difference between a biosimilar or an interchangeable biosimilar.
Summary: The Senate Business, Professions and Economic Development Committee heard SB 1094 by Senator Weber Pierson, which would expand pharmacist substitution authority for biosimilars and allow health plans to require use of lower-cost generic or biosimilar alternatives when available, unless the prescriber marks “do not substitute.” The author said the bill is intended to lower prescription drug costs, improve access, and require insurers to report on whether substitutions reduce out-of-pocket costs and premium growth. Committee amendments were accepted, including changes to align definitions with federal law, require a link to the FDA Purple Book, add a 30-day advance notice requirement for plan-driven substitutions, and allow exceptions for patients or providers. Supporters included Blue Shield of California, Sharp HealthCare, health plans, CVS, the California Chamber of Commerce, and other business and health care groups, who argued the bill would increase competition, reduce costs, and remove administrative barriers to using FDA-approved biosimilars. Opponents and “opposed unless amended” witnesses, including the Biotechnology Innovation Organization, the California Rheumatology Alliance, and some physician groups, argued the bill goes beyond current FDA interchangeability standards, could undermine physician judgment, and may create patient safety concerns for some chronic-disease patients who react differently to biosimilars or experience problems with multiple switches. Committee members discussed the “do not substitute” option, patient notification, insurance approval, and whether the bill preserves physician discretion. After debate, Senator Arreguín moved the bill, and the committee voted 10-0 to pass SB 1094 as amended to the Senate Health Committee.
LA

Louisiana 2026 Regular Session

Senate May 7th, 2026

Louisiana Senate Floor Meeting

Transcript Highlights:
  • in Titles 44 and 37, relative to psychology and the interjurisdictional compact, and provides for fees
  • recreational hunting licenses, to provide for a nonresident license for bear hunting and to establish the fee
  • This bill simply adds a nonresident bear hunting license and establishes a fee of $100.
  • and two estuble. licenses to provide for a non-resident license for bear hunting and to establish the fee
  • This bill simply adds a non-resident bear hunting license and establishes a fee of $100.
Bills: SB525 , SR112 , SR109 , SCR61 , SCR62 , SCR12 , HB175 , HB276 , HB437 , HB456 , HB457 , HB459 , HB488 , HB579 , HB656 , HB804 , HB818 , HB841 , HB981 , HB1052 , HB1089 , HB1101 , HB1154 , HB1166 , HB1193 , HB1194 , HB1203 , HB1209 , HB1244 , HB1249 , HB221 , HCR69 , HCR58 , SB57 , SB405 , SB414 , HB62 , HB193 , HB203 , HB205 , HB210 , HB220 , HB222 , HB228 , HB246 , HB420 , HB475 , HB486 , HB574 , HB584 , HB750 , HB799 , HB813 , HB815 , HB826 , HB870 , HB949 , HB953 , HB1045 , HB1092 , HB1151 , HB1162 , HB1176 , HB1177 , HB1196 , HB1214 , HB1236 , HB1241 , SB106 , SB206 , SB248 , SB441 , SR86 , SCR30 , SB83 , SB135 , SB143 , SB155 , SB157 , SB202 , SB237 , SB276 , SB295 , SB388 , SB450 , SB465 , SB35 , SB65 , SB215 , SB246 , SB249 , SB269 , SB282 , SB296 , SB323 , SB363 , SB369 , SB474 , SB484 , SB490 , SB492 , SB500 , SB501 , SB513 , HCR31 , HB301 , HB358 , HB359 , HB384 , HB413 , HB428 , HB450 , HB462 , HB547 , HB613 , HB631 , HB657 , HB669 , HB675 , HB680 , HB691 , HB712 , HB716 , HB720 , HB723 , HB727 , HB728 , HB735 , HB747 , HB759 , HB825 , HB845 , HB846 , HB903 , HB904 , HB907 , HB923 , HB929 , HB941 , HB962 , HB965 , HB1036 , HB287 , HB370 , HB515 , HB521 , HB570 , HB1200 , HB29 , HB39 , HB58 , HB67 , HB73 , HB76 , HB77 , HB82 , HB112 , HB121 , HB125 , HB132 , HB134 , HB151 , HB154 , HB155 , HB161 , HB166 , HB187 , HB191 , HB207 , HB211 , HB224 , HB238 , HB241 , HB242 , HB250 , HB260 , HB265 , HB275 , HB300 , HB320 , HB338 , HB339 , HB349 , HB379 , HB399 , HB427 , HB463 , HB464 , HB468 , HB545 , HB550 , HB551 , HB565 , HB588 , HB639 , HB725 , HB782 , HB805 , HB808 , HB834 , HB847 , HB853 , HB858 , HB861 , HB883 , HB916 , HB937 , HB977 , HB1012 , HB1027 , HB1044 , HB1054 , HB1091 , HB1117 , HB90 , HB127 , HB138 , HB150 , HB201 , HB268 , HB273 , HB285 , HB315 , HB354 , HB355 , HB360 , HB376 , HB445 , HB506 , HB606 , HB649 , HB665 , HB681 , HB721 , HB746 , HB757 , HB781 , HB835 , HB844 , HB857 , HB872 , HB886 , HB889 , HB892 , HB972 , HB982 , HB987 , HB1037 , HB1068 , HB1072 , HB1078 , HB1085 , HB1132 , HB1137 , HB1167 , HB1174 , HB1232 , HB1238 , HB23 , HB136 , HB36 , HB119 , HB126 , HB129 , HB245 , HB271 , HB280 , HB337 , HB351 , HB677 , HB726 , HB789 , HB850 , HB956 , HB966 , SB149 , SB382
TX

Texas 89th Regular

Insurance Mar 19th, 2025

Insurance

Transcript Highlights:
  • include the claims data that's in the APCD they're allowed to pull from peer-reviewed studies from FDA
  • Are y'all willing to supply that data as far as your administrative fees or costs?
  • Okay, well I'm worried about the administrative fee that y'all are going to charge us to make us pay.
  • So the increase of insurance more to take care of an administrative fee you're talking about well I'm
  • But if this cost is already included and the fees you're getting now.
Bills: HB138 , HB335 , HB388 , HB138
Committee: House Insurance
WA

Washington 2025-2026 Regular Session

Senate Floor Session Feb 28th, 2026 at 10:00 am

Washington Senate Floor Meeting

Transcript Highlights:
  • It is not about a new fee that individuals that have insurance will be paying.
  • They're large users of power. They create great, clean jobs.
  • I don't think we should do that for any tax or any fee.
  • We should have the courage to stand here every year that this Legislature Or any fee.
  • The reality is underage users don't get these products through normal retail sources.
AZ

Arizona 2026 Regular Session

02/18/2026 - Senate Government

Government

Transcript Highlights:
  • I represent the Arizona Municipal Power Users Association.
  • revenue from dues paid by an elected or appointed official using public monies to publicly disclose all fees
  • receives annual legislative appropriations. official using public monies to publicly disclose all fees
  • Namely, if someone is delinquent on his or her fees, this lengthens the window out to 18 months, at which
NH

New Hampshire 2026 Regular Session

House Judiciary (01/14/2026)

Judiciary

Transcript Highlights:
  • And it is my client who bears the risk of failure because my client is going to pay my fees no matter
  • And it is my client who bears the risk of failure because my client is going to pay my fees no matter
  • </c> ...going to pay my fees no matter what.
  • </c> a simple contingency, uh, fee a simple contingency, uh, fee arrangement,<01:47:11.120><c> which<
  • I did not uh crypto users to the IRS.
Committee: House Judiciary
NH

New Hampshire 2026 Regular Session

House Ways and Means (01/12/2026) (Full Stream)

Ways and Means

Transcript Highlights:
  • So, it's an income-based fee.
  • </c> &gt;&gt; people it's an income based fee. &gt;&gt; people it's an income based fee.
  • </c> the FDA. the FDA. &gt;&gt; Oh,<00:39:10.400><c> thank</c><00:39:10.480><c> you.
  • This tax or this fee is similar to a lot of the other fees that basically stay flat.
  • . fees. fees.
NM

New Mexico 2025 Regular Session

IC - Legislative Health and Human Services Jun 26th, 2025

Legislative Health & Human Services Committee

Transcript Highlights:
  • Julie Meade: So some of the core strategies for the remediation funds are naloxone and other FDA approved
  • What is not, what is one possible solution in terms of stabilizing the lives of these substance users
  • It's a clinical setting where the substance user goes in there.
  • For the substance users, for our communities, for their families. Thank you, Madam Chair.
  • thinking about where we could see savings, and ensure that people are not turn out to be very expensive users
NH
Transcript Highlights:
  • </c> Dumel's data analysis to senior FDA Dumel's data analysis to senior FDA officials.<00:52:09.359>
  • Sarsman, who was a in FDA, that Dr.
  • </c> of data as clearly seen in the CDC FDA. of data as clearly seen in the CDC FDA.
  • It comes from FDA and CDC itself.
  • It comes from FDA and CDC itself.
Summary: The New Hampshire House Special Committee on the COVID Response Efficacy met to continue its fact-finding review of the state’s pandemic response, with the chair restating the committee’s mission and focus on federal guidance, federal funding, emergency use authorization vaccination efforts, long COVID, patient rights, and vaccination policies. The chair said the committee had previously reviewed materials about the U.S. Supreme Court declining to hear a COVID vaccine case and CDC internal emails about vaccine risks, and introduced additional research on CDC testing and communications failures. A large portion of the meeting was devoted to summarizing articles and a recent U.S. Senate Permanent Subcommittee on Investigations report titled *Unmasked: How Biden Health Officials Purposely Turned a Blind Eye Toward COVID-19 Vaccine Safety Signals*. The chair argued that CDC testing and guidance were flawed, citing delayed data publication, confusing guidance, a faulty early COVID test, missed opportunities to study silent spread, and alleged suppression of safety information. The Senate report was described as alleging that FDA and CDC officials knew their surveillance systems could mask vaccine safety signals, that officials discouraged internal analysis from being shared externally, and that newer analytical methods identified multiple statistically significant adverse-event signals. The chair also discussed the V-safe system, VAERS, and claims that federal officials downplayed or concealed adverse-event data. Members and the chair connected these federal issues to New Hampshire, noting changes in the state’s health care landscape since the pandemic, including more urgent care facilities and satellite ERs. The chair suggested New Hampshire should develop independent scientific assessment resources to validate federal information in future emergencies. Representative Wheeler noted that the materials would be entered into the committee record and made available on the House website. No votes were taken; the committee discussed the materials, invited further questions, and indicated that a proposed committee communication would be revisited later after additional supporting information is gathered, with a goal of issuing a statement by the end of June.
MO

Missouri 2026 Regular Session

Health and Mental Health Jan 29th, 2026 at 08:00 am

Health and Mental Health

Transcript Highlights:
  • The one in question that we should hear from FDA on January 31st, which is really soon, whether the sublingual
  • It was given to the FDA late fall, early winter, and they said that on the 31st of January, they'll give
  • Representative Bennie Cook, and just to quickly refresh your memory, that does help with our drug abuse users
Summary: The committee first met in executive session and approved a combined House Committee Substitute for House Bills 2642, 2296, 1996, and 1680 on a 15-0 vote after adopting a committee amendment and substitute. It then adopted a substitute for House Bill 2596, which expanded access for sole proprietors with at least one common law employee and their dependents, and passed that bill do pass by a 15-0 vote. The committee then heard several health-related bills. House Bills 2194, 2349, 1826, and 2560 focused on expanding epinephrine access in schools, child care facilities, nursing homes, and first responder settings to include nasal sprays and other delivery systems, with testimony emphasizing the need for easier administration, training, and broader school nurse support. House Bill 1827 would add occupational therapists to the list of professionals who can certify disability parking placards and plates, with supporters saying OTs already perform the functional assessments needed. House Bill 1783 would let the Department of Health and Senior Services contract with nonprofit public health institutes to help administer federal public health grants and reduce lapsed funds; supporters said the state lacks staffing capacity, while some members raised concerns about oversight and fraud. Finally, Representative Peters presented House Bill 2372, a large omnibus health bill combining many previously heard measures, including epinephrine delivery system updates, pseudoephedrine purchase limit changes, doula participation in Mo HealthNet, telehealth, workplace violence signage, long-term care inspection changes, RX CARES sunset removal, 340B language, anesthesia time protections, and other provisions. Support came from numerous medical, nursing, pharmacy, public health, and provider groups, while opposition focused mainly on the 340B provisions, non-opioid alternative language, anesthesia contracting language, and telehealth standards, arguing those sections needed separate consideration and stronger transparency safeguards.
CA

California 2025-2026 Regular Session

Assembly Education Committee Mar 12th, 2025

Transcript Highlights:
  • language in the Education Code that refers to epinephrine in one way, an auto-injector, to encompass all FDA-approved
  • This last year, the FDA approved the first needleless option of epinephrine, with more in the pipeline
  • information and media literacy, including AI literacy, to educate students to be critical thinkers and users
Summary: The Assembly Education Committee met for its first hearing of the session, adopted its committee rules on a 6-0 vote, and then heard several bills. AB 347, which would require written notice to students about the right to opt out of animal dissection and receive a comparable assignment, drew strong support from the author, a student, and multiple advocacy and education groups, while opponents argued it would burden teachers and duplicate existing law. The committee approved AB 347 on a 7-0 vote and sent it to Appropriations. AB 281, which would expand parent access to sex education materials and require disclosure of outside consultants’ credentials, drew mixed testimony. Supporters framed it as a transparency and parent-rights measure, while school administrators and county education officials said current law already allows inspection and that the bill would create an unfunded administrative burden. After extended member discussion, the bill failed on a 4-3 vote with one abstention, though reconsideration was granted. AB 65, which would provide paid pregnancy leave for educators without requiring them to exhaust sick leave first, was supported by teachers, CTA, and the State Treasurer, but opposed by school administrators and business officials over cost concerns; it passed 6-0 to Higher Education. The committee also approved AB 361, which would extend and expand LAUSD’s best-value procurement authority for school construction to all school districts for five years, on a 5-0 vote with one abstention. AB 86, which would require the State Board of Education to adopt standardized K-8 health education instructional materials, passed 5-0. Finally, AB 228, the Zaki Fast Act, was introduced to clarify that schools may stock any federally approved epinephrine delivery system, including newer devices beyond auto-injectors, and was presented with testimony from the bill’s young namesake and his family; the transcript cuts off before the committee vote on that measure.
FL

Florida 2026 5th Special Session

Regulated Industries Jan 27th, 2026

Transcript Highlights:
  • would not apply to nicotine dispensing devices that have received marketing authorization from the FDA
  • So they are being sold today without FDA approval in convenience stores, in... ...they are being sold
  • today without FDA approval in convenience stores, in gas stations, across the country, et cetera, et
  • There is not federal or state enforcement dollars to engage with us, nor has there been FDA... ...to
  • approved—and I like the idea of... ...they themselves are not FDA approved.
Summary: The Committee on Regulated Industries met and reported several bills favorably. SB 530 on state lotteries was presented with two technical amendments and passed as amended. The bill revises Department of Lottery powers and duties, updates bid/proposal information requirements, adds definitions related to ball machines, and gives the department more flexibility to purchase rather than lease machines. SB 204 also passed favorably; it increases penalties for illegal slot machine operations to a third-degree felony and creates a process for veteran service organizations to seek binding declaratory statements from the Gaming Commission about whether a machine is lawful. Testimony on SB 204 included support from Florida Gaming and soft opposition from a veteran organization that wanted clearer language and more cooperation on electronic bingo-type games. The committee then took up a combined proposed committee substitute merging SB 658 and SB 608 on water safety requirements for rental and residential properties. The merged bill requires certain rental properties near water bodies or with swimming pools to have specified safety devices, such as exit alarms, self-closing/self-latching locks, pool fences, pool covers, or pool alarms, and allows DBPR enforcement for vacation rentals. Supporters emphasized the bill’s goal of preventing child drownings, citing Florida’s high number of fatal drownings and the disproportionate impact on young children and children with autism. The combined bill was reported favorably. SB 980 on nicotine dispensing devices was amended with a delete-all amendment creating the Florida Agegate Act. The substitute bill restricts advertising, promotion, and display of non-FDA-approved nicotine devices in retail settings accessible to those under 21, sets escalating penalties, directs fine revenue to enforcement and youth prevention, and authorizes inspections and warrantless searches tied to retail permits. Members discussed whether the bill would effectively curb illegal and counterfeit products and how enforcement would work; the sponsor said the measure is intended to reduce youth access in light of limited enforcement resources. The bill passed favorably. SB 1708 on veterinary licensure by endorsement also passed, removing a three-year out-of-state practice requirement for licensed veterinarians while keeping other qualifications intact to help address veterinary shortages. Finally, SB 680 on electric vehicle charging taxation passed with a strike-all amendment creating a sales tax exemption for electricity sold to EV charging station operators and transferred to consumers, provided it is separately metered and properly documented. The committee adjourned after noting additional support forms and inviting members to a later K-12 speech and debate bill presentation.
FL

Florida 2026 Regular Session

Regulated Industries Jan 27th, 2026

Regulated Industries

Transcript Highlights:
  • So they are being sold today without FDA approval in convenience stores, in...
  • This does not apply to the federally approved, FDA-approved nicotine devices, but only the ones who are
  • There is not federal or state enforcement dollars to engage with us, nor has there been FDA...
  • The reality is these products are, so it is the non-approved FDA product is um...”
  • “The non-approved FDA product is supposed to be, is essentially not approved to be sold in this way,
Bills: S0530 , S0658 , S0608 , S1708 , S0680 , S0980 , S0204
Summary: The Committee on Regulated Industries considered and reported several bills. SB 530 on state lotteries was presented with two technical amendments adopted, including changes to lottery department contracting language and machine-purchase flexibility; the committee then reported the bill favorably. SB 204, which increases penalties for illegal slot machine operations to a third-degree felony and creates a declaratory-statement process for veteran service organizations to confirm machine legality, drew support from gaming interests and some soft opposition from a veterans group concerned about implementation; it was also reported favorably. The committee then took up a proposed committee substitute combining SB 658 and SB 608 on water safety requirements for rental and vacation properties. The combined bill would require certain rental properties near water bodies or with pools to install specified alarms, locks, fences, covers, or similar safety devices, with enforcement through DBPR and a grace period for correcting some violations. Senators emphasized the bill as a response to child drowning deaths, including those involving autistic children, and the PCS was reported favorably. SB 980, as a delete-everything amendment, would create the Florida Agegate Act to restrict advertising, promotion, and display of non-FDA-approved nicotine devices in areas accessible to those under 21, with penalties and inspection authority; after questions about counterfeit products and enforcement, it was reported favorably. The committee also approved SB 1708, which removes a three-year out-of-state practice requirement for veterinary licensure by endorsement while keeping other competency requirements, and SB 680, as amended, which creates a sales tax exemption for electricity sold to EV charging station operators and transferred to consumers, subject to metering and affidavit requirements. Several members recorded votes after the roll calls, and the meeting ended with an invitation to return later for another bill before adjournment.
KY

Kentucky 2026 Regular Session

House Standing Committee on Veterans, Military Affairs, and Public Protection (3-24-26)

Veterans, Military Affairs, & Public Protection

Transcript Highlights:
  • I also have experience with the<00:05:55.600><c> FDA.</c> the FDA. the FDA.
  • </c> to fund FDA approval for ibogaine. to fund FDA approval for ibogaine.
  • </c> The estimated total cost for FDA The estimated total cost for FDA approval<00:09:37.600><c> is</
  • Ibogaine,</c><00:10:26.480><c> Kentucky</c> Once the FDA approves Ibogaine, Kentucky Once the FDA approves
  • </c> Ibogaine is approved by the FDA. Ibogaine is approved by the FDA.
TX

Texas 89th Regular

S/C on Disease Prevention & Women's & Children's Health Mar 20th, 2025

S/C on Disease Prevention & Women's & Children's Health

Transcript Highlights:
  • The FDA already regulates this. That's a fallacy. They do not regulate this.
  • What the FDA is telling us at this point.
  • I mean, our country, if we have problems with the FDA, let's fix the process of the FDA.
  • You were talking about the FDA moving this to 2029.
  • Um, one timely example is the recent FDA ban of the food coloring red 3.
Bills: HB25 , HB38 , HB997 , HB 1119 , HB25 , HB38
FL

Florida 2026 Regular Session

Regulated Industries Jan 27th, 2026

Regulated Industries

Transcript Highlights:
  • So they are being sold today without FDA approval in convenience stores, in... ...they are being sold
  • today without FDA approval in convenience stores, in gas stations, across the country, et cetera, et
  • There is not federal or state enforcement dollars to engage with us, nor has there been FDA... ...to
  • The non-approved FDA product is supposed to be—essentially not approved to be sold in this way—but it
  • approved—and I like the idea of... ...they themselves are not FDA approved.
Bills: S0530 , S0658 , S0608 , S1708 , S0680 , S0980 , S0204
Summary: The Committee on Regulated Industries met and reported several bills favorably. SB 530 on state lotteries, presented by Senator Pizzo, made technical changes to the Department of Lottery’s powers and duties, clarified definitions, and allowed more flexibility to purchase rather than lease machines; two technical amendments were adopted before the bill passed. SB 204, also presented by Senator Bradley, increased penalties for illegal slot machine operations to a third-degree felony and created a process for veteran service organizations to seek binding declaratory statements from the Gaming Commission about whether a machine is lawful; the bill was reported favorably after testimony from supporters and a veteran organization expressing concern about clarity and good-faith cooperation. SB 658 and SB 608 were combined into a proposed committee substitute on water safety for rental and vacation properties, requiring certain pool or water safety devices and adding enforcement provisions through DBPR; the merged bill was reported favorably after strong testimony emphasizing child drowning statistics and support from local residents and industry representatives. SB 980, as amended, created the Florida Agegate Act to restrict advertising, promotion, and display of non-FDA-approved nicotine dispensing devices around minors, with escalating penalties and inspection authority; members discussed concerns about illegal products and enforcement, and the bill was reported favorably. SB 1708 on veterinary licensure by endorsement removed a three-year recent practice requirement for out-of-state veterinarians while keeping other competency standards, and it was reported favorably with support from several animal and veterinary-related groups. SB 680, as amended, addressed double taxation of electricity used at EV charging stations by creating a sales tax exemption for separately metered electricity transferred to consumers, and it was also reported favorably. The committee also noted additional support forms for the water safety bill and adjourned after miscellaneous remarks and announcements.